Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) - Total Liabilities

Latest as of September 2025: CN¥2.10 Billion CNY ≈ $306.95 Million USD

Based on the latest financial reports, Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has total liabilities worth CN¥2.10 Billion CNY (≈ $306.95 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 603392 cash flow metrics to assess how effectively this company generates cash.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Beijing Wantai Biological Pharmacy Enter (603392) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors by Total Liabilities

The table below lists competitors of Beijing Wantai Biological Pharmacy Enterprise Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Sunny Optical Technology (Group) Company Limited F:SXC	Germany	€29.20 Billion
Charles River Laboratories NYSE:CRL	USA	$4.06 Billion
Kiwoom KO:039490	Korea	₩65.89 Trillion
Companhia Paranaense de Energia - COPEL NYSE:ELPC	USA	$36.10 Billion
Vibra Energia S.A. SA:VBBR3	Brazil	R$39.65 Billion
Vicinity Centres AU:VCX	Australia	AU$5.19 Billion
The Federal Bank Limited NSE:FEDERALBNK	India	Rs3.31 Trillion
Storebrand ASA OL:STB	Norway	Nkr988.14 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Beijing Wantai Biological Pharmacy Enterprise Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 603392 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.26	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.17	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2024)

The table below shows the annual total liabilities of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥2.24 Billion ≈ $327.99 Million	-20.83%
2023-12-31	CN¥2.83 Billion ≈ $414.31 Million	-22.74%
2022-12-31	CN¥3.66 Billion ≈ $536.25 Million	+47.56%
2021-12-31	CN¥2.48 Billion ≈ $363.41 Million	+168.98%
2020-12-31	CN¥923.29 Million ≈ $135.11 Million	+58.05%
2019-12-31	CN¥584.19 Million ≈ $85.49 Million	+31.50%
2018-12-31	CN¥444.24 Million ≈ $65.01 Million	-41.30%
2017-12-31	CN¥756.80 Million ≈ $110.74 Million	+52.96%
2016-12-31	CN¥494.76 Million ≈ $72.40 Million	+30.57%
2015-12-31	CN¥378.93 Million ≈ $55.45 Million	+68.27%
2014-12-31	CN¥225.19 Million ≈ $32.95 Million	+0.12%
2013-12-31	CN¥224.92 Million ≈ $32.91 Million	--

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology

Market Cap

$7.92 Billion

CN¥54.10 Billion CNY

Market Cap Rank

#2647 Global

#337 in China

Share Price

CN¥42.79

Change (1 day)

+5.21%

52-Week Range

CN¥37.95 - CN¥78.36

All Time High

CN¥142.90